202 related articles for article (PubMed ID: 24368420)
1. Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.
Huang X; Liu F; Zhu C; Cai J; Wang H; Wang X; He S; Liu C; Yao L; Ding Z; Zhang Y; Zhang T
Dig Dis Sci; 2014 Apr; 59(4):795-806. PubMed ID: 24368420
[TBL] [Abstract][Full Text] [Related]
2. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
4. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
6. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
8. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
9. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
10. Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.
Hu B; Yan X; Liu F; Zhu C; Zhou H; Chen Y; Liu J; Gu X; Ni R; Zhang T
Pathol Oncol Res; 2016 Jul; 22(3):555-65. PubMed ID: 26715439
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
13. Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.
Shi W; Huang W; Chen Y; Zhang S; Xu P; Gu X; Fan H; Xu J; Chen Y; Ni R; Lu C; Zhang X
Tumour Biol; 2016 Aug; 37(8):10447-57. PubMed ID: 26846109
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
15. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
[TBL] [Abstract][Full Text] [Related]
16. Kinesin family member 2C aggravates the progression of hepatocellular carcinoma and interacts with competing endogenous RNA.
Zhang GP; Shen SL; Yu Y; Yue X; Hu WJ; Li SQ
J Cell Biochem; 2020 Nov; 121(11):4419-4430. PubMed ID: 32056305
[TBL] [Abstract][Full Text] [Related]
17. KIF3B Promotes the Proliferation of Pancreatic Cancer.
Liu ZH; Dong SX; Jia JH; Zhang ZL; Zhen ZG
Cancer Biother Radiopharm; 2019 Aug; 34(6):355-361. PubMed ID: 31157987
[No Abstract] [Full Text] [Related]
18. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma.
Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L
Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
20. General transcription factor IIb overexpression and a potential link to proliferation in human hepatocellular carcinoma.
Li L; Zhang A; Cao X; Chen J; Xia Y; Zhao H; Shen A
Pathol Oncol Res; 2013 Apr; 19(2):195-203. PubMed ID: 23055019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]